Alogliptin: A New Addition to the Class of DPP-4 Inhibitors
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - New Zealand
doi 10.2147/dmso.s4312
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2009
Authors
Publisher
Informa UK Limited